Related references
Note: Only part of the references are listed.Daratumumab is effective in the relapsed or refractory systemic light-chain amyloidosis but associated with high infection burden in a frail real-life population
Zoe Van de Wyngaert et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial
Maria-Victoria Mateos et al.
LANCET (2020)
CD157: From immunoregulatory protein to potential therapeutic target
Erika Ortolan et al.
IMMUNOLOGY LETTERS (2019)
Preemptive therapy for cytomegalovirus reactivation after daratumumab-containing treatment in patients with relapsed and refractory multiple myeloma
Ryo Nakagawa et al.
ANNALS OF HEMATOLOGY (2019)
A phase 1b study of isatuximab plus pomalidomide/dexamethasone in relapsed/refractory multiple myeloma
Joseph Mikhael et al.
BLOOD (2019)
Daratumumab: A Review in Combination Therapy for Transplant-Ineligible Newly Diagnosed Multiple Myeloma
Yahiya Y. Syed
DRUGS (2019)
Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma
Hareth Nahi et al.
PLOS ONE (2019)
Increased TLR4 Expression Aggravates Sepsis by Promoting IFN- Expression in CD38-/- Mice
Qi Li et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Exploring the complex role of chemokines and chemoattractants in vivo on leukocyte dynamics
Bruna A. David et al.
IMMUNOLOGICAL REVIEWS (2019)
Cellular traffic through afferent lymphatic vessels
Philipp Schineis et al.
VASCULAR PHARMACOLOGY (2019)
Subcutaneous delivery of daratumumab in relapsed or refractory multiple myeloma
Saad Z. Usmani et al.
BLOOD (2019)
The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases
Kelly A. Hogan et al.
FRONTIERS IN IMMUNOLOGY (2019)
Low Cellular NAD+ Compromises Lipopolysaccharide-Induced Inflammatory Responses via Inhibiting TLR4 Signal Transduction in Human Monocytes
Kuan Yang et al.
JOURNAL OF IMMUNOLOGY (2019)
CD157 Confers Host Resistance to Mycobacterium tuberculosis via TLR2-CD157-PKCzeta-Induced Reactive Oxygen Species Production
Qianting Yang et al.
MBIO (2019)
Exosomes in Sepsis and Inflammatory Tissue Injury
Eun J. Park et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
Daratumumab added to standard of care in patients with newly diagnosed multiple myeloma: A network meta-analysis
Wenjun Xu et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2019)
HIV Disease Progression: Overexpression of the Ectoenzyme CD38 as a Contributory Factor?
Juan C. Rodriguez-Alba et al.
BIOESSAYS (2019)
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study
Michel Attal et al.
LANCET (2019)
Pro-inflammatory agents released by pathogens, dying host cells, and neutrophils act synergistically to destroy host tissues: a working hypothesis
Isaac Ginsburg et al.
JOURNAL OF INFLAMMATION RESEARCH (2019)
Brief report: Clinical experiences after emergency use of daratumumab monotherapy for relapsed or refractory multiple myeloma in real practice
Sung-Soo Park et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2019)
CD38 modulates respiratory syncytial virus-driven proinflammatory processes in human monocyte-derived dendritic cells
Ilaria Schiavoni et al.
IMMUNOLOGY (2018)
Host-directed therapies for bacterial and viral infections
Stefan H. E. Kaufmann et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Inhibiting the CD38/cADPR pathway protected rats against sepsis associated brain injury
Qian-Yi Peng et al.
BRAIN RESEARCH (2018)
Blockade of CD38 diminishes lipopolysaccharide-induced macrophage classical activation and acute kidney injury involving NF-κB signaling suppression
Bingyan Shu et al.
CELLULAR SIGNALLING (2018)
Liver X Receptor Nuclear Receptors Are Transcriptional Regulators of Dendritic Cell Chemotaxis
Susana Beceiro et al.
MOLECULAR AND CELLULAR BIOLOGY (2018)
CD38 Is Robustly Induced in Human Macrophages and Monocytes in Inflammatory Conditions
Stephanie A. Amici et al.
FRONTIERS IN IMMUNOLOGY (2018)
Control of Listeria monocytogenes infection requires classical IL-6 signaling in myeloid cells
Karsten Luecke et al.
PLOS ONE (2018)
Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma
Ajai Chari et al.
CANCER (2018)
CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
Fabio Morandi et al.
FRONTIERS IN IMMUNOLOGY (2018)
Inhibition of Inflammasome-Dependent Interleukin 1β Production by Streptococcal NAD+-Glycohydrolase: Evidence for Extracellular Activity
Dora Hancz et al.
MBIO (2017)
The Nuclear Receptor LXR Limits Bacterial Infection of Host Macrophages through a Mechanism that Impacts Cellular NAD Metabolism
Jonathan Matalonga et al.
CELL REPORTS (2017)
Phagocytosis: A Fundamental Process in Immunity
Carlos Rosales et al.
BIOMED RESEARCH INTERNATIONAL (2017)
The immunopathology of sepsis and potential therapeutic targets
Tom van der Poll et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma
Jakub Krejcik et al.
BLOOD (2016)
CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism
Juliana Camacho-Pereira et al.
CELL METABOLISM (2016)
Reduced Plasmodium Parasite Burden Associates with CD38+ CD4+ T Cells Displaying Cytolytic Potential and Impaired IFN-γ Production
Julie G. Burel et al.
PLOS PATHOGENS (2016)
Exosome Biogenesis, Regulation, and Function in Viral Infection
Marta Alenquer et al.
VIRUSES-BASEL (2015)
Binding of CD157 Protein to Fibronectin Regulates Cell Adhesion and Spreading
Simona Morone et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
CD38 and CD157: A long journey from activation markers to multifunctional molecules
Valeria Quarona et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2013)
Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38 Implications for Cellular NAD+ Metabolism, Protein Acetylation, and Treatment of Metabolic Syndrome
Carlos Escande et al.
DIABETES (2013)
CD38 Controls the Innate Immune Response against Listeria monocytogenes
Timo Lischke et al.
INFECTION AND IMMUNITY (2013)
Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome
Takuma Misawa et al.
NATURE IMMUNOLOGY (2013)
The Role of CD38 in Fcγ Receptor (FcγR)-mediated Phagocytosis in Murine Macrophages
John Kang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Lipopolysaccharide induces CD38 expression and solubilization in J774 macrophage cells
Cha-Uk Lee et al.
MOLECULES AND CELLS (2012)
Ectonucleotidase CD38 Demarcates Regulatory, Memory-Like CD8+ T Cells with IFN-γ-Mediated Suppressor Activities
Rajia Bahri et al.
PLOS ONE (2012)
Quantitative proteomic analysis of exosomes from HIV-1-infected lymphocytic cells
Ming Li et al.
PROTEOMICS (2012)
The Membrane-Bound Enzyme CD38 Exists in Two Opposing Orientations
Yong Juan Zhao et al.
SCIENCE SIGNALING (2012)
Tetrameric Interaction of the Ectoenzyme CD38 on the Cell Surface Enables Its Catalytic and Raft-Association Activities
Miki Hara-Yokoyama et al.
STRUCTURE (2012)
Flavonoids as inhibitors of human CD38
Esther Kellenberger et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
CD38 Through the Life of a Murine B Lymphocyte
Felipe Vences-Catalan et al.
IUBMB LIFE (2011)
The CD157-Integrin Partnership Controls Transendothelial Migration and Adhesion of Human Monocytes
Nicola Lo Buono et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Absence of CD38 delays arrival of neutrophils to the liver and innate immune response development during hepatic amoebiasis by Entamoeba histolytica
L. A. Estrada-Figueroa et al.
PARASITE IMMUNOLOGY (2011)
The PI3K p110δ Regulates Expression of CD38 on Regulatory T Cells
Daniel T. Patton et al.
PLOS ONE (2011)
Exosomes from human lymphoblastoid B cells express enzymatically active CD38 that is associated with signaling complexes containing CD81, Hsc-70 and Lyn
Esther Zumaquero et al.
EXPERIMENTAL CELL RESEARCH (2010)
Antigen-induced clustering of surface CD38 and recruitment of intracellular CD38 to the immunologic synapse
Pilar Munoz et al.
BLOOD (2008)
Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology
Fabio Malavasi et al.
PHYSIOLOGICAL REVIEWS (2008)
Chemotaxis of mouse bone marrow neutrophils and dendritic cells is controlled by ADP-Ribose, the major product generated by the CD38 enzyme reaction
Santiago Partida-Sanchez et al.
JOURNAL OF IMMUNOLOGY (2007)
CD38/CD19: a lipid raft-dependent signaling complex in human B cells
Silvia Deaglio et al.
BLOOD (2007)
CD38 cross-linking enhances TLR-induced B cell proliferation but decreases IgM plasma cell differentiation
Nataly Manjarrez-Orduno et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
CD38 plays a role in effective containment of mycobacteria within granulomata and polarization of Th1 immune responses against Mycobacterium avium
Marta S. Viegas et al.
MICROBES AND INFECTION (2007)
Regulation of intracellular levels of NAD: A novel role for CD38
Pinar Aksoy et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
TNF regulates cellular NAD+ metabolism in primary macrophages
J Iqbal et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells
L Frasca et al.
BLOOD (2006)
MHC class II/CD38/CD9: a lipid-raft-dependent signaling complex in human monocytes
MT Zilber et al.
BLOOD (2005)
Early proliferation of CCR5+ CD38+++ antigen-specific CD4+ Th1 effector cells during primary HIV-1 infection
JJ Zaunders et al.
BLOOD (2005)
CD38 is expressed on human mature monocyte-derived dendritic cells and is functionally involved in CD83 expression and IL-12 induction
G Fedele et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Regulation of dendritic cell trafficking by the ADP-ribosyl cyclase CD38:: Impact on the development of humoral immunity
S Partida-Sánchez et al.
IMMUNITY (2004)
Chemotaxis and calcium responses of phagocytes to formyl peptide receptor ligands is differentially regulated by cyclic ADP ribose
S Partida-Sánchez et al.
JOURNAL OF IMMUNOLOGY (2004)
Human CD38 interferes with HIV-1 fusion through a sequence homologous to the V3 loop of the viral envelope glycoprotein gp120.
A Savarino et al.
FASEB JOURNAL (2003)
Innate immunity is regulated by CD38, an ecto-enzyme with ADP-ribosyl cyclase activity
S Partida-Sanchez et al.
MICROBES AND INFECTION (2003)
CD38 ligation plays a direct role in the induction of IL-1β, IL-6, and IL-10 secretion in resting human monocytes
R Lande et al.
CELLULAR IMMUNOLOGY (2002)
Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo
S Partida-Sánchez et al.
NATURE MEDICINE (2001)
Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus/host interactions?
A Savarino et al.
AIDS (2000)
Share Paper
